Category: Drug Discovery
Europe Drug Discovery
-
Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification, and Lead Optimization), and By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Small molecule drugs have represented some of the crucial blockbusters in the ... Read More
-
Cardiovascular Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $19.1 and in terms of global GDP, the market was 0.16%. Cardiovascular drugs was the fourth largest segment within the market accounting for 10.0% preceded and followed by central nervous ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $12.7 and in terms of global GDP, the market was 0.11%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.7% preceded and followed ... Read More
-
Ophthalmology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $6.6 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.4% preceded and followed by gastrointestinal drugs ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $10.7 and in terms of global GDP, the market was 0.09%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.6% preceded and followed ... Read More
-
Genito-Urinary Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $5.2 and in terms of global GDP, the market was 0.04%. Genito-urinary drugs was the eleventh largest segment within the market accounting for 2.7% preceded and followed by dermatology drugs ... Read More
-
Oncology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $26.0 and in terms of global GDP, the market was 0.23%. Oncology drugs was the second largest segment within the market accounting for 13.7% preceded and followed by anti-infective drugs ... Read More
-
Dermatology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $6.4 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ophthalmology drugs ... Read More
-
Hematology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $4.2 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.7% ... Read More
-
Central Nervous System Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... In terms of per capita consumption, the market was $22.0 and in terms of global GDP, the market was 0.19%. Central nervous system drugs was the third largest segment within the market accounting for 11.6% ... Read More
-
Gastrointestinal Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $9.3 and in terms of global GDP, the market was 0.08%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.9% preceded and followed by metabolic disorders ... Read More
-
Respiratory Diseases Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... of per capita consumption, the market was $18.5 and in terms of global GDP, the market was 0.16%. Respiratory diseases drugs was the fifth largest segment within the market accounting for 9.8% preceded and followed ... Read More
-
Sjogren’s Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others (Pain Relief Medication and late phase drug)), by type (Primary and Secondary), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Sjogren’s syndrome is systematic autoimmune disorder which effect the entire body, along ... Read More
-
Live Cell Imaging Market, By Product (Equipment, Consumables, and Software and Services), By Application (Cell Biology, Developmental Biology, Stem Cell Biology, Drug Discovery, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Live cell imaging is the study of living cells using time-lapse microscopy. This technique has revolutionized cell biology by facilitating ... Read More
-
Europe Underactive Bladder Market - Industry Trends and Forecast to 2029
... contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation Europe Underactive Bladder Market, By Treatment (Pharmacotherapy, Surgical Methods, Urethral Assist ... Read More
-
Europe Artificial Intelligence (AI) in Drug Discovery Market - Industry Trends and Forecast to 2029
... period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029. Market Segmentation Europe Artificial ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market, By Product (Therapeutics [Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Other Therapeutics] and Diagnostics [Brain Imaging and CSF Test for Alzheimer’s Disease]) and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Alzheimer's disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of ... Read More
-
Immunotherapy Drugs Market, By Product (Monoclonal Antibodies, Immuno Modulators, Car T-Cell Therapy, Others), By Applications (Cancer, Autoimmune & Inflammatory Diseases, Others), and By Geography (Europe, APAC, North America, Latin America, And Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. Immunotherapy is preferable than the old technique as it helps treat a ... Read More
-
Europe Alzheimer’s Disease Therapeutics And Diagnostics Market 2022-2028
... duration of 2022-2028. Germany, Spain, the United Kingdom, Italy, France, and Rest of Europe are included in the market in this region. A network of “memory centers,” which specialize in neurodegenerative disease diagnosis, has been ... Read More
-
Contract Pharmaceutical Manufacturing Market, by Service Type (Contract Manufacturing Organization (CMO) (API Manufacturing, Final Dosage Form Manufacturing, and Packaging), Contract Research Organization (CRO) (Drug Discovery, Preclinical Studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... III, Phase IIIb – IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development)), by Molecule Type (Small Molecules and Large Molecules), and by Region (North America, Latin America, Europe, ... Read More
-
Oncology Drugs Market, by Drug Type (Cytotoxic Drugs (Alkylating Agents, Antimetabolites, and Others), Targeted Drugs (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, and Others), and Hormonal Drugs (Ovarian Function Blockers, Estrogen Production Blockers, and Estrogen’s Effect Blockers (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... (Selective Estrogen Receptor Modulators (SERMs) and Others)), by Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Bladder Cancer, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and ... Read More
-
Global Axial Spondyloarthritis Market, By Commercialized Therapies (Anti-Tumour Necrosis Factor Therapy(TNF),Anti-Interleukin Therapy(IL), Anti-Janus Kinase Therapy(JAK)); By Potential Pipeline Products (Anti-Janus Kinase Therapy(JAK), Anti-Interleukin (IL)-17 Therapy, Other) ;By Indication(Ankylosing Spondylitis, Non-Radiographic Axial Spondylitis); By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028.
... America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028. Global Axial Spondyloarthritis Market to Reach USD 4.95 Billion by 2028 The growth of the ... Read More
-
Europe Compound Management Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Sample Type (Chemical Compounds and Bio Samples), By End User, By Country and Growth Forecast, 2022 - 2028
... Europe Compound Management Market would witness market growth of 14.8% CAGR during the forecast period (2022-2028). The methods by which numerous distinct compounds are tested for their activity are essential to drug discovery. These substances ... Read More
-
ENT Disorder Treatment Market, by Treatment Type (Devices (Hearing Aid Devices, Voice Prosthesis, Nasal Splints, Hearing Implants and Others) and Drug Type (Antibiotics, Antihistamines, Steroids, Anti-inflammatory Drugs, Others)), by Organ Type (Ear, Nose, and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 ... Read More
-
Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Recombinant DNA (rDNA) technology is a novel technique that has led to advances in a number of ... Read More
Research Assistance
